-- Podcast to be Available Following Conference Call --
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 30, 2008--Alkermes, Inc. (NASDAQ: ALKS) will host a conference call at 4:30 p.m. EST on Thursday, November 6, 2008 to discuss the company's financial results for its second quarter of fiscal 2009. Management will review the quarter and provide an update on the company.
The conference call will be webcast on the investor relations section of Alkermes' website at www.alkermes.com or may be accessed by dialing 1-866-256-9239 for domestic callers and 1-703-639-1213 for international callers. The conference call ID number is 1298438.
A replay of the conference call will be available from 7:30 p.m. EST on Thursday, November 6, 2008 through 5:00 p.m. EST on Thursday, November 13, 2008, and may be accessed by visiting Alkermes' website or by dialing 1-888-266-2081 for domestic callers and 1-703-925-2533 for international callers. The replay access code is 1298438. Alkermes is also providing a podcast MP3 file available for download on the Alkermes website, which will be available shortly following the conference call and will be available until Thursday, November 13, 2008.
About Alkermes
Alkermes, Inc., a biotechnology company committed to developing innovative medicines to improve patients' lives, manufactures RISPERDAL(R) CONSTA(R) for schizophrenia and developed and manufactures VIVITROL(R) for alcohol dependence. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research and manufacturing facilities in Massachusetts and Ohio.
CONTACT: Alkermes, Inc. Eva Stroynowski, 617-583-6823 Associate, Corporate Communications SOURCE: Alkermes, Inc.